Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoff G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

Short-term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits
William E. Smiddy, MD
Annual Meeting Talks
2021
Retinal Sequelae of Corona Virus 2019 (COVID-19) Infection and Its Management: A Consecutive Case Series
Mallika Goyal, MD
On Demand Cases, Courses, and Papers
2021
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022

Category: Socioeconomics

See more